|Articles|February 20, 2019

Hospital Antimicrobial Stewardship Programs Have Significant Value With Beneficial Clinical and Economic Impacts

Hospital antimicrobial stewardship programs (ASPs) aim to promote judicious use of antimicrobials to combat antimicrobial resistance. For ASPs to be developed, adopted and implemented, an economic value assessment is essential. Few studies demonstrate the cost-effectiveness of ASPs. This systematic review by Nathwani, et al. (2019) aimed to evaluate the economic and clinical impact of ASPs.

An update to the Dik et al. systematic review (2000-2014) was conducted on EMBASE and Medline using PRISMA guidelines. The updated search was limited to primary research studies in English (Sept. 30, 2014 to Dec. 31, 2017) that evaluated patient and/or economic outcomes after implementation of hospital ASPs including length of stay (LOS), antimicrobial use, and total (including operational and implementation) costs.

One hundred forty-six studies meeting inclusion criteria were included. The majority of these studies were conducted within the last fiveâyears in North America (49%), Europe (25%), and Asia (14%), with few studies conducted in Africa (3%), South America (3%), and Australia (3%). Most studies were conducted in hospitals with 500â1000 beds and evaluated LOS and change in antibiotic expenditure, the majority of which showed a decrease in LOS (85%) and antibiotic expenditure (92%). The mean cost-savings varied by hospital size and region after implementation of ASPs. Average cost savings in U.S. studies were $732 per patient (range: $2.50 to $2640), with similar trends exhibited in European studies. The key driver of cost savings was from reduction in LOS. Savings were higher among hospitals with comprehensive ASPs which included therapy review and antibiotic restrictions.

The researchers conclude that their data indicates that hospital ASPs have significant value with beneficial clinical and economic impacts. More robust published data is required in terms of implementation, LOS, and overall costs so that decision-makers can make a stronger case for investing in ASPs, considering competing priorities. Such data on ASPs in lower- and middle-income countries is limited and requires urgent attention.

Reference: Nathwani D, et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrobial Resistance & Infection Control. 2019;8:35

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Related to this article

Image of Pathogens flying (Adobe Stock weerasak)

October 6th, 2026

How 3 Decades of SHEA Presidents Shaped the Science and Soul of Infection Prevention

Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.

October 5th, 2026

How Can OR and Sterile Processing Teams Improve Collaboration and Instrument Readiness?

Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.

Weekly Rounds With Infection Control Today

October 2nd, 2026

ICT Weekly Rounds: Genomic Surveillance Wins, Reprocessing Drift, and a Century-Old Measles Warning

This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.

Picture of the award. (Photos used with permission.)

October 1st, 2026

UPMC’s Genomic Surveillance Award Opens the Door to Funding Conversations

UPMC’s genomic surveillance initiative earned national recognition for patient safety. Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, explains how the award could help infection preventionists secure leadership support and sustainable funding for earlier outbreak detection.

Figure 1: Dental Environment/Phase; Estimated Share of Risk/Incidents; and Common Sharp Items Involved (Figure credit author with AI)

September 30th, 2026

The Clean Bite: Making Dental Infection Control Part of Every Day

Knowing the protocol is only the beginning. In The Clean Bite, Sherrie Busby explores how explaining the why, addressing staff concerns, and creating clear procedures can help dental teams make infection control part of everyday practice.

Environmental services personnel doing cleaning in the operating room (Adobe Stock 248152636 by karrastock)

September 30th, 2026

How Purposeful Infection Prevention Rounding Supports Patient Safety and EVS Collaboration

What might infection prevention rounds miss when visible conditions dominate the conversation? Tommy Davis, PhD, CMIP, a member of ICT's executive advisory board, makes the case for structured observations of clinical workflows, shared accountability, and greater attention to environmental services staff’s insights.

September 29th, 2026

Proposed AHRQ Cut Raises Questions About Infection Prevention Research and Support

A proposed $27.7 million reduction in AHRQ funding raises questions about support for infection prevention research and implementation. Here is what the September 25 announcement identifies, as well as what remains unknown about specific IPC programs.

Karen Jones, MPH, RN, CIC, FAPIC (Image credit: author)